Archive for Daniel Grossman

Abortion groups tell women to lie about abortion pill, claim miscarriage

Posted in Abortion pill, Abortion Pills Illegal, DANCO, Packard Foundation, Self Managed Abortion, self-managed abortion with tags , , , , , , , , , , , , , , , , , , , on June 2, 2019 by saynsumthn

abortion pill

Just as abortion supporters rage over new pro-life laws in Georgia and Alabama, claiming that women could be investigated for miscarriages, comes proof that abortion supporters are actually advising women who experience complications from illegal use of the abortion pill to lie to health care providers and say they had miscarriages.

Currently, abortion insiders, many with ties to abortion pill manufacturer Danco, are pushing for expansion of the abortion pill, despite thousands of adverse effects and two dozen deaths. The abortion pill regimen consists of two drugs: Mifepristone  (or Mifeprex) and Misoprostol. The FDA has warned women against purchasing these dangerous pills online.

Dr. Daniel Grossman, a professor of obstetrics and gynecology at the University of California, San Francisco, who also teaches abortion allegedly told a reporter at The Atlantic that if women using these [self-managed abortion] regimens experience heavy bleeding or some other complication, they are generally advised to go to a hospital and say they had a miscarriage.

Grossman is behind clinical trials to expand the abortion pill for pharmacy dispension and is calling to remove important safety requirements put in place by the FDA, called REMS. This comes as no surprise, as one of the major original investors of abortion pill manufacturer Danco — The Packard Foundation — has funded other Grossman-authored studies. In other words, those behind the studies attempting to do away with FDA safety requirements for the abortion pill stand to gain a significant amount of money if those requirements are removed.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )


If you think you might have a complication you should go to a doctor immediately. If you live in a place where abortion is a crime and you don’t have a doctor you trust, you can still access medical care. You do not have to tell the medical staff that you tried to induce an abortion; you can tell them that you had a spontaneous miscarriage. Doctors have the obligation to help in all cases and know how to handle a miscarriage.
The international abortion organization, Women on Web, advises women on its website to present to the ER and claim they are having a miscarriage if they experience complications from the abortion pill in a country where taking the drug is illegal:

The symptoms of a miscarriage and an abortion with pills are exactly the same and the doctor will not be able to see or test for any evidence of an abortion, as long as the pills have completely dissolved. 

Women on Web advises women lie about illegal abortion pill emergencies say miscarriage (accessed 5/14/2019)

According to a report from The Atlantic, Women on Web’s founder, Rebecca Gomperts, launched the site Aid Access to sell the abortion pill online, against FDA requirements. The FDA recently issued Aid Access a warning letter to cease its illegal activity. Last week, over 100 lawmakers sent a letter to the FDA, asking it to continue to monitor and crack down on dangerous websites like Aid Access.

But that has not stopped other proponents of self-managed abortion, who seem set on placing women in harm’s way. The website Plan C, founded in 2015 by Francine Coeytaux and Elisa Wells, tells women, “Those who choose to self-manage their abortion have no obligation to report that they have used misoprostol and there is no way it can be detected in the body, even if a blood test is taken. Scientists have found that there is no noticeable difference between a naturally occurring miscarriage and the bleeding that happens after taking misoprostol.”

Plan C Website FAQ where get

Then, if something goes wrong (and it most likely will), the Plan C website, which is under the fiscal sponsorship of the National Women’s Health Network, advises women to present to the emergency room or other health care offices and simply claim they are experiencing a miscarriage.

PlanC website tells women aborting to present with Miscarriage, accessed 5/14/2019

Live Action News previously reported how abortion organization, Reproaction, purchased over $4,000 in ads to promote a push for self-managed abortion — something unapproved by the FDA. Reproaction also advises women to seek care by lying about their abortions.

A webinar published in 2018 states in part that women “need information to reduce the risk of arrest… what the signs of a complication are and most importantly what to say if one needs to go to the doctor…. [T]he symptoms of an abortion with pills and miscarriage are exactly the same and the treatment for any kind of complication is exactly the same…. It’s important for people to understand there’s no test for these pills in blood or urine so if they present with a miscarriage they can get the healthcare that they need….”

tweet from “Helen Bolton” — whose profile implies that he or she is with organized abortion groups “ and ” — reiterates the deception being proposed: “Misoprostol is basically OTC in a lot of the world and is regularly used to self-manage abortions in places where it’s illegal. Even with complications, the patient looks like they had a miscarriage, so people can go to a hospital (provided miscarriages aren’t investigated).”

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

Others have made similar suggestions.

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

FDA warns women: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

According to the FDA’s adverse effects reports through 2018, there have been reports of 24 deaths associated with Mifeprex since the product was approved in September 2000, as well as 4,200 reported adverse effects, including hospitalization and other serious complications.

  • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Media ignores profit motive of researcher attempting to discredit abortion pill reversal

Posted in Abortion pill, Abortion Pill Connections, Abortion Pill Study, Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Clinical Trial APR, Contraception Journal, DANCO, Daniel Grossman, Mitchell D. Creinin, Population Council, Reproductive Health Professionals (ARHP), RU-486, University o California San Francisco (UCSF), University of California, University of California Davis with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

abortion pill birth control

 

The principal investigator of a study seeking to disprove the legitimacy of abortion pill reversal has direct ties — including financial ties — to abortion pill manufacturer Danco, which was formed by the eugenics-founded Population Council. This potential conflict of interest should demand scrutiny from the media — but instead, the media willingly questions abortion pill reversal based upon a single “expert” that receives compensation from Danco. This “expert” is Mitchell D. Creinin, a professor at University of California, Davis, sponsor of the study.

Mitchell Creinin has long history with abortion. He is an abortionist who was involved in clinical trials of RU-486 at Magee-Women’s Hospital Dept. of OB/GYN Pittsburgh, PA. He was the previous medical and lab director of Planned Parenthood of Western Pennsylvania, as described by Oxford University Press. He worked on an abortion training publication for the National Abortion Federation (NAF). He has served on the Board of Directors for the Association for Reproductive Health Professionals (ARHP). He is also listed among the advisory counsel for the early abortion training guide published by Advancing New Standards in Reproductive Health (ANSIRH), part of UCSF’s Bixby Center for Global Reproductive Health.

As I detailed in a Twitter thread shown below, Creinin’s abortion history and connections to the abortion pill’s manufacturer are deep and worth mentioning. This calls into question the validity of his study into abortion pill reversal. Creinin has financial incentive to make sure the abortion pill remains in demand, as do the study’s sponsors. This is a blatant conflict of interest.

Carole Novielli@CaroleNovielli

Person behind “Clinical Trial” to attempt to disprove abortion pill reversal (APR) – connected to abortion and takes money from abortion pill manufacturer- can you say CONFLICT? https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

 

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

3/ Mitchell D Creinin is Professor at University of California, Davis (UCD) – the anti-APR study’s sponsor more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/ceovZv7Uqr

See Carole Novielli’s other Tweets
View image on Twitter

Carole Novielli@CaroleNovielli

4/ Mitchell D Creinin is a consultant for abortion pill manufacturer, receiving consulting fees $$/ honorarium f/ DANCO https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/GZ4s3kfmSp

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

5/ Mitchell D Creinin provided “third-party telephone consults,” for pill (Mifeprex or RU486) DANCO – formed by Population Council
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/MsAH2mXW7v

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

6/ Creinin founding member of Society of Family Planning (SFP) began w/ Packard Foundation $$ – which is funding abortion pill studies/ publications. SFP funding study- granted UC Davis $401,764. https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/FTtWWM90gm

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

7/ Creinin, deputy editor SFP’s journal Contraception, publishes Packard-funded reports promoting self-managed abortion. Funds Gynuity which sponsors abortion pill expansion studies https://www.liveaction.org/news/exposed-conflicts-interest-abortion-pill/  more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/CarYNczMXg

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

8/ Packard’s investment seeded abortion pill MFG, DANCO including a $14 million loan as early as 1996 to bring drug RU486 (Mifepristone) to US Packard funds UC Davis sponsor of study https://www.liveaction.org/news/secrecy-abortion-pill-maker-investors/  More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/SYzUaTfwHV

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

9/ Creinin is Principal Investigator (PI) in another clinical trial by abortionist on pharmacy dispension of abortion pill https://www.liveaction.org/news/this-abortionist-claims-abortion-pill-doesnt-need-regulations-hes-wrong/ 
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

10/ Creinin previous medical/lab director Planned Parenthood of Western Pennsylvania – and an abortionist involved in original clinical trials of RU-486 abortion pill

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

11/ In summary- FOLLOW THE MONEY – something this @VICE report FAILED to do – https://news.vice.com/en_us/article/j5wqqp/theres-no-proof-abortion-reversals-are-real-this-study-could-end-the-debate 
These abortion “studies” are tied together by $$ from / Danco support from

There’s no proof “abortion reversals” are real. This study could end the debate.

Four states already mandate that doctors advise women their abortions can be reversed.

news.vice.com

See Carole Novielli’s other Tweets

As shown in the Twitter thread above, Creinin serves as consultant for abortion pill (Mifeprex) manufacturer, Danco, and receives consulting fees and compensation from the company. In addition, he receives honorarium from Danco. Creinin also provides “third-party telephone consults” for Danco. Creinin’s study sponsor is financed by the Packard Foundation, one of Danco’s major financial investors.

If this all weren’t enough to show a major conflict of interest, Creinin is also a founding member of the Society of Family Planning, which is collaborating on the study. This organization’s mission is to support abortion research, it, too, is funded by the Packard Foundation. Creinin is also the deputy editor of SFP’s official journalContraceptionPackard-funded studies in this journal unsurprisingly support the pro-abortion cause, claiming self-managed abortion is safe, and urging the undoing of current FDA safety standards restricting dispensation of the abortion pill (known as REMS). The Journal’s editorial board has been stacked with abortion industry insiders, including a National Abortion Federation board member and members of the Population Council (responsible for bringing the abortion pill into the US and forming DANCO, the manufacturer of the pill).  Obviously, the journal is pro-abortion.

Creinin is also the principal investigator in another clinical trial run abortionist/researcher Daniel Grossman (professor at University of California, San Francisco) on pharmacy dispension of the abortion pill.

Despite the fact that this conflict exists between the study’s “investigator” and Danco, media outlets ignore it. Such was the case over at Vice, which published the latest attack against abortion pill reversal, highlighting Creinin’s study without drawing one line to his connections to the abortion pill’s manufacturer. Vice headlined their hit piece: “THERE’S NO PROOF ‘ABORTION REVERSALS’ ARE REAL. THIS STUDY COULD END THE DEBATE,” in spite of the fact that Creinin’s study is only at the recruiting stage, and hasn’t reached any conclusions yet.

Or has it?

Creinin makes no secret that he doesn’t believe in abortion pill reversal  — and his profitable relationship with Danco should give any critically thinking person reason to question the motivations behind this push to “test” the effectiveness of the abortion pill reversal protocol.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Abortion strategy to fund abortion and bio-waste facilities, pass legislation

Posted in Abortion Strategy, ANSIRH, Guttmacher, Reproductive Health Investors Allianc, TARA Health Foundation with tags , , , , , , , , , , , , , , , , , , , , , , on September 6, 2018 by saynsumthn

EXPOSED: Abortion groups’ plan to ‘increase supply and demand’ for abortion

A 92-page report on the Tara Health Foundation website should be reviewed by pro-life advocates across the nation, as it details upcoming strategy from abortion supporters, which includes the push for “home use” abortions. Live Action News has previously covered how the philanthropic Foundation is behind funding RU-486 pills on college campuses in California and behind propping up the abortion chain Whole Woman’s Health while it battled safety regulations in Texas.

The “US Reproductive Health Investment Case” report from October of 2017 was put together by the “Reproductive Health Investors Alliance… to determine the most effective opportunities to improve access to reproductive health services… using both philanthropy and impact investments.” The report’s stated goal? “To increase the supply of and demand for… contraceptive and abortion services.”

Image: TARA Reproductive Health Investors Alliance Goal

TARA Reproductive Health Investors Alliance Goal

Image: Reproductive Health Investors Alliance Steering Committee

Reproductive Health Investors Alliance Steering Committee

The report includes statistics and analysis from “ANSIRH, the Guttmacher Institute, Ibis Reproductive Health, and the Kaiser Family Foundation.”

It should be noted that these agencies have abortion connections:

“Experts” who contributed to the report include:

The executive summary begins by pointing out the target:

… specific demographic groups (18-19 year olds, Black [WOC] and Hispanic women, and low-income women) that lag behind the national average in their rates of contraceptive use, the efficacy of contraceptives used and timing of abortion.

Live Action News has documented time and again that minority groups, which have a disproportionately high rate of abortion, are the target of the population control movement.

Image: TARA Reproductive Health Investors Alliance targeting women of color

TARA Reproductive Health Investors Alliance targeting women of color

The report identifies “40 example investment opportunities,” matched to “five challenge-specific investment strategies”:

a) research and development,
b) legislation & litigation,
c) pricing & reimbursement,
d) service provision, and
e) care-seeking by underserved populations

As Live Action News has documented, the report states that, “~50% of abortions are repeat abortions (460K abortions/year)” and it defines “woman” as those “in need of high quality contraceptive and abortion services” though the report “acknowledge[s] that this is a vast simplification.” The report also adds, “The term ‘woman’ does not describe the identity of all persons who can get pregnant; conversely, not all those who identify as a woman can get pregnant.”

Image: TARA Reproductive Health Investors Alliance legislative strategies

TARA Reproductive Health Investors Alliance legislative strategies

Pro-abortion legislative and litigation strategies suggested in the report include:

  • REMS removal strategy (This is the risk management system that governs the abortion pill RU486)
  • TRAP laws removal advocacy
  • Gestational bans removal advocacy
  • Criminality of self-induced abortion removal advocacy
  • Organizing led by women of color
  • Reproductive health or democracy reform PAC donations
  • Reproductive justice PAC donations

Image: Reproductive Health Investors Alliance abortion clinic strategy 1 of 2

Reproductive Health Investors Alliance strategy 1 of 2

Strategies that benefit abortion facilities include:

  • Investment in a biowaste facility that will collect from the facilities
  • Upstream investment to secure supply of firms able to build the facilities
  • Guarantees that enable the facilities to take out market rate loans
  • Readily available real estate or rental agreements for the facilities
  • Facilitate and train NPs, CNMs, PAs to commit abortions
  • Provide funding or loans for independent providers to join a telemedicine network
  • Innovations in telemedicine, mobile services, or at-home services that improve access
  • Provide free pregnancy diagnosis in abortion facilities to combat pregnancy resource centers

Image: Reproductive Health Investors Alliance abortion clinic strategy 2 of 2

Reproductive Health Investors Alliance strategy 2 of 2

Statistics from report unintentionally point to pro-life advances:

  • Since 2010, 338 state abortion restrictions have been adopted.
  • 90% of all U.S. counties lack an abortion provider.
  • 162 abortion providers closed down between 2011-2016. Only 21 abortion facilities opened during the same period.
  • An estimated 16 abortion facilities close each year due to financial challenges.
  • As of 2008, 97% of nonmetropolitan counties lacked an abortion provider.
  • There are an estimated 2,300 to 3,500 CPCs in the U.S. while there are only 1,800 abortion facilities.
  • Pregnancy resource centers outnumber these facilities 2:1.
  • Cost and difficulty getting malpractice insurance for independent providers is one of the biggest financial challenges for already resource strapped abortion facilities.
  • Viewing an ultrasound may contribute to a small proportion of women with medium or low decision certainty deciding to continue the pregnancy.
  • More than a third of Planned Parenthood’s budget comes from Medicaid, putting Planned Parenthood at risk if Medicaid funding is blocked.

The report proves the length abortion supporters intend to go to in order to guarantee the “right” to end the lives of tiny humans persons in the womb. And it clearly shows the impact that pro-life legislation, pro-life activism, and pro-life pregnancy centers are having on the abortion industry.

This article is reprinted with permission. The original appeared here at Live Action News.